Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9
Completed
Conditions studied: Cataracts, Astigmatism
In brief
The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.
Key facts
- Study ID
- NCT01601665
- Run by
- Alcon Research
- People needed
- 477
- Starts
- 2012-02-01
- Expected to finish
- 2015-07-01
- Last updated by the study team
- 2015-08-04
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with bilateral cataracts and in the targeted astigmatism range.
- Planned cataract removal by phacoemulsification.
- Pupil size greater than or equal to 6 mm after dilation.
- Able to undergo second eye surgery within 30 days of first eye surgery.
- Other protocol-defined inclusion criteria may apply.
You may not qualify if…
- Irregular corneal astigmatism.
- Any inflammation or swelling of the cornea.
- Any corneal abnormality other than regular corneal astigmatism.
- Previous corneal refractive surgery.
- Amblyopia.
- Diabetic retinopathy.
- Uncontrolled glaucoma.
- Currently participating in another investigational drug or device study that may confound the results of this investigation.
- Other protocol-defined exclusion criteria may apply.
Where it is running
- Contact Alcon Call Center for Trial Locations — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.